Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target Raised to $60 00 at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – HC Wainwright decreased their FY2023 earnings estimates for shares of Longboard Pharmaceuticals in a report issued on Monday, January 8th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings per share of ($2.28) for the year, down from their previous estimate of ($2.14). […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its price target boosted by HC Wainwright from $25.00 to $60.00 in a report published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Longboard Pharmaceuticals’ Q4 2023 earnings at ($0.52) EPS, FY2023 earnings at ($2.28) EPS, […]
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $24.85, but opened at $23.79. Longboard Pharmaceuticals shares last traded at $24.55, with a volume of 64,839 shares trading hands. Wall Street Analysts Forecast Growth LBPH has been the subject […]